This point is relevant as it is well-known that the immune response needs both the help mediated by the recognition of CD4+ T cells of MHC-II-restricted peptides and the lytic activity of CD8+ T cells restricted to MHC-I antigens to eliminate tumor cells (185) (Figure 4). This evidence concerns the gene CD8A and neoplasm.